The tweet was deleted by the author.
But we saved everything 🙂.
CVRx announced that Baylor Scott & White Health is continuing to expand patient access to Barostim for individuals living with heart failure.
The update highlights a partnership with Baylor Scott & White Medical Center and several clinicians. This development marks a further rollout of CVRx’s Barostim therapy in a key U.S. healthcare system, reflecting growing adoption and clinical use.
View post on X Loading...
CVRx recently backed Endeavor Health’s first Barostim procedure to expand treatment options for heart failure patients, as reported in a previous article. The company also supported the first Barostim implant at Glens Falls Hospital, bringing the device to local patients, according to earlier coverage. These initiatives mark additional steps in Barostim’s rollout to U.S. healthcare systems.